ATOSSA THERAPEUTICS, INC. — All Filings
620 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B2
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEL AM
EFFECT
FWP
POS AM
PRE 14A
RW
S-1
S-1/A
S-3
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| CORRESP | — | 0001144204-12-034086 | Jun 11, 2012 | — |
| S-1/A | FORM S-1/A | 0001144204-12-034079 | Jun 11, 2012 | — |
| UPLOAD | — | 0000000000-12-029161 | Jun 6, 2012 | — |
| S-1/A | FORM S-1/A | 0001144204-12-030728 | May 21, 2012 | — |
| UPLOAD | — | 0000000000-12-020301 | Apr 20, 2012 | — |
| S-1/A | AMENDMENT NO.1 TO FORM S-1 | 0001144204-12-020447 | Apr 6, 2012 | — |
| UPLOAD | — | 0000000000-12-012671 | Mar 12, 2012 | — |
| S-1 | FORM S-1 | 0001144204-12-007893 | Feb 14, 2012 | — |
| D/A | — | 0001488039-11-000001 | Jun 24, 2011 | — |
| D | — | 0001519810-11-000001 | May 13, 2011 | — |
| RW | — | 0001144204-11-008734 | Feb 15, 2011 | — |
| S-1/A | — | 0001144204-11-006053 | Feb 4, 2011 | — |
| S-1/A | — | 0001144204-11-001397 | Jan 10, 2011 | — |
| S-1/A | — | 0001144204-10-066740 | Dec 16, 2010 | — |
| S-1/A | — | 0001144204-10-063028 | Nov 23, 2010 | — |
| S-1 | S-1 | 0001144204-10-051825 | Oct 1, 2010 | — |
| D/A | — | 0001488039-10-000002 | Sep 28, 2010 | — |
| RW | — | 0001144204-10-039594 | Jul 28, 2010 | — |
| D | — | 0001488039-10-000001 | Jun 24, 2010 | — |
| S-1 | — | 0001144204-10-016530 | Mar 30, 2010 | — |